Anti-B3GNT8 antibodies are used in the immunodetection of the protein UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8. In humans, the canonical protein has a reported length of 397 amino acid residues and a mass of 43.4 kDa. Its subcellular localization is in the Golgi. It is reported to be highly expressed in small intestine, pancreas, spleen, bone marrow, lung, throat, and ileum, and weakly in fetal brain, cerebellum, heart, liver, tongue, breast, uteri, and testis. A member of the Glycosyltransferase 31 protein family, B3GNT8 is a reported Beta-1,3-N-acetylglucosaminyltransferase that plays a role in the elongation of specific branch structures of multiantennary N-glycans. Synonyms for this target antigen include UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 7, beta galactosyltransferase BGALT15, beta-1,3-Gn-T8, beta-1,3-N-acetylglucosaminyltransferase 8, and BGnT-8. B3GNT8 gene orthologs have been reported in the mouse, rat, bovine and chimpanzee species. Immunohistochemistry is a widely used application for the B3GNT8 antibodies listed below. In addition, Western Blot is also a common application.